CompuGroup Medical plans to double its dividend

CompuGroup Medical SE & Co. KGaA (CGM), based in Koblenz, has announced its intention to significantly increase the dividend paid to its shareholders. Indeed, for the financial year 2023, the company is proposing a dividend of 1.00 EUR per share, which would total dividend payments of 52.2 million EUR, compared to 26.1 million EUR the previous year. This proposal follows the improvement of the available cash flow profile and the strength of CGM's business model, thus fostering a sustainable increase in the dividend level while continuing to invest in future growth.

The dividend proposal, which corresponds to a yield of 2.6% based on the closing price at the end of 2023, will be submitted for approval at the Annual General Meeting. Michael Rauch, CEO of CompuGroup Medical, emphasized the company's ability to reward its shareholders through the strength of its financial results and business model. Preliminary financial results for the year 2023 were released in early February, and the full annual report will be available on the company's website on March 28, 2024.